脂毒性
医学
肾功能
内分泌学
蛋白尿
内科学
血管内皮生长因子
肾
肾脏疾病
疾病
糖尿病
肾小球硬化
内皮功能障碍
胰岛素抵抗
血管内皮生长因子受体
作者
Annelie Falkevall,Annika Mehlem,Isolde Palombo,Benjamin Heller Sahlgren,Lwaki Ebarasi,Liqun He,Anders Jimmy Ytterberg,Hannes Olauson,Jonas Axelsson,Birgitta Sundelin,Jaakko Patrakka,Pierre D. Scotney,Andrew D. Nash,Ulf Eriksson
出处
期刊:Cell Metabolism
[Cell Press]
日期:2017-02-09
卷期号:25 (3): 713-726
被引量:179
标识
DOI:10.1016/j.cmet.2017.01.004
摘要
Summary
Diabetic kidney disease (DKD) is the most common cause of severe renal disease, and few treatment options are available today that prevent the progressive loss of renal function. DKD is characterized by altered glomerular filtration and proteinuria. A common observation in DKD is the presence of renal steatosis, but the mechanism(s) underlying this observation and to what extent they contribute to disease progression are unknown. Vascular endothelial growth factor B (VEGF-B) controls muscle lipid accumulation through regulation of endothelial fatty acid transport. Here, we demonstrate in experimental mouse models of DKD that renal VEGF-B expression correlates with the severity of disease. Inhibiting VEGF-B signaling in DKD mouse models reduces renal lipotoxicity, re-sensitizes podocytes to insulin signaling, inhibits the development of DKD-associated pathologies, and prevents renal dysfunction. Further, we show that elevated VEGF-B levels are found in patients with DKD, suggesting that VEGF-B antagonism represents a novel approach to treat DKD.
科研通智能强力驱动
Strongly Powered by AbleSci AI